GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (FRA:RGO) » Definitions » Inventories, Other

Regeneron Pharmaceuticals (FRA:RGO) Inventories, Other : €716 Mil (As of Mar. 2025)


View and export this data going back to 1990. Start your Free Trial

What is Regeneron Pharmaceuticals Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Regeneron Pharmaceuticals's other inventories for the quarter that ended in Mar. 2025 was €716 Mil.

Regeneron Pharmaceuticals's quarterly other inventories increased from Sep. 2024 (€691 Mil) to Dec. 2024 (€693 Mil) and increased from Dec. 2024 (€693 Mil) to Mar. 2025 (€716 Mil).

Regeneron Pharmaceuticals's annual other inventories declined from Dec. 2022 (€493 Mil) to Dec. 2023 (€479 Mil) but then increased from Dec. 2023 (€479 Mil) to Dec. 2024 (€693 Mil).

Regeneron Pharmaceuticals Inventories, Other Historical Data

The historical data trend for Regeneron Pharmaceuticals's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Inventories, Other Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 354.20 396.92 492.58 478.77 693.04

Regeneron Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 562.58 669.53 690.80 693.04 715.86

Regeneron Pharmaceuticals Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Regeneron Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (FRA:RGO) » Definitions » Inventories, Other
Comparable Companies
ALNY ONC BNTX SMMT RPRX INSM BMRN INCY MRNA EXEL VRTX ASX:CSL XKRX:207940 XBRU:ARGX XBRU:UCB XKRX:068270 XKRX:196170 OCSE:GMAB HKSE:02269 SHSE:603392
Traded in Other Exchanges
REGN:USA REGN:Mexico 0R2M:UK REGN34:Brazil REGN:Austria
Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Website
https://www.regeneron.com
Regeneron Pharmaceuticals Inc discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Regeneron Pharmaceuticals Headlines

No Headlines